Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06596226 · ClinicalTrials.gov registry record · NA

Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism

A NA study of Autism, sponsored by The University of Texas at Dallas.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06596226: Recruiting NA study of Autism, sponsored by The University of Texas at Dallas.

NCT06596226 is a NA study of Autism that is actively recruiting participants, run by The University of Texas at Dallas. The registered enrollment target is 80 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06596226, a NA study of Autism, is actively recruiting participants, sponsored by The University of Texas at Dallas.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

Purpose of the Study: The goal of this clinical trial is to find out if a technique called the "mutual gaze procedure," used in Pathways Early Intervention (Pathways), is the key to helping improve social communication, language, and everyday skills in young children (16-30 months old) who are at high risk for autism, particularly those from diverse cultural and language backgrounds. What Will Happen: Researchers will compare two versions of the Pathways Intervention: * Version 1: Includes mutual gaze strategies. * Version 2: Does not include mutual gaze strategies. What to Expect: Participants will: * Attend 12 sessions of Pathways Intervention, each lasting 1.5 hours (or 15 weeks if there are cancellations). * Come to the clinic for a developmental check-up three times: before starting Pathways, right after completing Pathways, and three months after finishing Pathways.

Primary Outcome

Assessors blind to group assignment will evaluate each child for social skills using the EarliPointTM The EarliPointTM is an FDA-authorized eye-tracking tool that uses artificial intelligence (AI) eye-tracking technology to assess social disability in children between 16 and 30 months by measuring the number of social interactions a child observes on the portable eye-tracking screen. EarliTech will be used to measure improved social skills. There are 2 different EarliTech Scores: social disabili

Conditions Studied

Interventions

  • BEHAVIORAL Pathways Parent Mediated Intervention
  • BEHAVIORAL Pathways Parent Mediated Intervention without Mutual Gaze

Study Locations (1)

Texas

  • University of Texas at Dallas - Richardson

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-09-10
Est. Completion 2026-06-01
Phase NA
The University of Texas at Dallas

50 total trials

What NCT06596226 shows while recruiting

NCT06596226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (56% lower).

The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 2 interventions - of which Pathways Parent Mediated Intervention is the first listed.

NCT06596226 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06596226 about?

NCT06596226 is a clinical study titled "Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism". Purpose of the Study: The goal of this clinical trial is to find out if a technique called the "mutual gaze procedure," used in Pathways Early Intervention (Pathways), is the key to helping improve social communication, language, and everyday skills in young children (16-30 months old) who are at hi...

What is the current status of trial NCT06596226?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-09-10. Estimated completion is 2026-06-01.

What conditions does trial NCT06596226 study?

This clinical trial studies the following conditions: Autism.

What interventions are being tested in trial NCT06596226?

The interventions under investigation include: Pathways Parent Mediated Intervention (BEHAVIORAL), Pathways Parent Mediated Intervention without Mutual Gaze (BEHAVIORAL).

Who is sponsoring clinical trial NCT06596226?

This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06596226 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06596226's enrollment target sits among peer trials

80 44th of 104 higher than 58 of 104 other Autism trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06596226, the US trial registry maintained by the National Library of Medicine. NCT06596226 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.